{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:28:34Z","timestamp":1792384114770,"version":"4.4.0"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018625","name":"Science and Technology Support Project in Biomedical Field of Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejmech.2025.117281","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:20:31Z","timestamp":1737159631000},"page":"117281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Recent advances in small molecule design strategies against hepatic fibrosis"],"prefix":"10.1016","volume":"286","author":[{"given":"Heming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8289-097X","authenticated-orcid":false,"given":"Zhe-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0927-9023","authenticated-orcid":false,"given":"Tingfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117281_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117281_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41575-023-00846-4","article-title":"Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease","volume":"21","author":"Feng","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117281_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tox.2008.06.013","article-title":"Hepatic fibrosis\u2014overview","volume":"254","author":"Friedman","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.ejmech.2025.117281_bib4","doi-asserted-by":"crossref","unstructured":"S. Ge Phillip, A. Runyon Bruce, Treatment of patients with cirrhosis, N. Engl. J. Med., 375 767-777.","DOI":"10.1056\/NEJMra1504367"},{"key":"10.1016\/j.ejmech.2025.117281_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117281_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2025.117281_bib7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.yexcr.2017.02.038","article-title":"Modulation of hepatic stellate cells and reversibility of hepatic fibrosis","volume":"352","author":"Huang","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejmech.2025.117281_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1183\/09031936.00185114","article-title":"Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review","volume":"46","author":"Hutchinson","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ejmech.2025.117281_bib9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3390\/cells10051097","article-title":"Pathophysiology and treatment options for hepatic fibrosis: can it Be completely cured?","volume":"10","author":"Khanam","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117281_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117281_bib11","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117281_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166235","article-title":"Nuclear receptors in liver fibrosis","volume":"1867","author":"K\u00f6nigshofer","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2025.117281_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/hep.32299","article-title":"A strategy of vascular\u2010targeted therapy for liver fibrosis","volume":"76","author":"Lin","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.117281_bib14","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.apsb.2023.10.023","article-title":"Epigenetic modification in liver fibrosis: promising therapeutic direction with significant challenges ahead","volume":"14","author":"Liu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117281_bib15","article-title":"Hepatocellular carcinoma","volume":"2","author":"Llovet","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejmech.2025.117281_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ebiom.2019.02.002","article-title":"Fighting liver fibrosis to reduce mortality associated with chronic liver diseases: the importance of new molecular targets and biomarkers","volume":"40","author":"Muriel","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2025.117281_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.ejmech.2025.117281_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/nrgastro.2016.3","article-title":"Management of NAFLD: a stage-based approach","volume":"13","author":"Rinella","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117281_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2025.117281_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: direct antifibrotic agents and targeted therapies","volume":"68\u201369","author":"Schuppan","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejmech.2025.117281_bib21","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-\u03b2 signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.117281_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153294","article-title":"Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-\u03b2\/Smad and YAP signaling","volume":"78","author":"Xiang","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.117281_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","article-title":"Targeting fibrosis: mechanisms and clinical trials","volume":"7","author":"Zhao","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2025.117281_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bpg.2017.04.005","article-title":"Reversal of liver fibrosis: from fiction to reality","volume":"31","author":"Zoubek","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.ejmech.2025.117281_bib25","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3390\/molecules23071644","article-title":"Discovery of matrinic thiadiazole derivatives as a novel family of anti-liver fibrosis agents via repression of the tgf\u03b2\/smad pathway","volume":"23","author":"Niu","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117281_bib26","doi-asserted-by":"crossref","first-page":"7969","DOI":"10.1021\/acs.jmedchem.3c00286","article-title":"Evolution and discovery of matrine derivatives as a new class of anti-hepatic fibrosis agents targeting ewing sarcoma breakpoint region 1 (EWSR1)","volume":"66","author":"Bao","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103032","article-title":"Novel cytisine derivatives exert anti-liver fibrosis effect via PI3K\/Akt\/Smad pathway","volume":"90","author":"Tang","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib28","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.3390\/molecules25214977","article-title":"Structure\u2013activity relationship of aloperine derivatives as new anti\u2013liver fibrogenic agents","volume":"25","author":"Wang","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117281_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2022.105176","article-title":"Rational design, synthesis and activities of phenanthrene derivatives against hepatic fibrosis","volume":"159","author":"Li","year":"2022","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2025.117281_bib30","doi-asserted-by":"crossref","first-page":"10573","DOI":"10.1021\/acs.jmedchem.8b01165","article-title":"Design, synthesis, and antifibrosis activity in liver of nonsecosteroidal vitamin D receptor agonists with phenyl-pyrrolyl pentane skeleton","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115596","article-title":"Design, synthesis and anti-hepatic fibrosis activity of novel diphenyl vitamin D receptor agonists","volume":"258","author":"Xing","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106795","article-title":"Design, synthesis, and biological evaluation of carbonyl-hydrazine-1-carboxamide derivatives as anti-hepatic fibrosis agents targeting Nur77","volume":"140","author":"Hu","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107113","article-title":"Structure-based design and synthesis of anti-fibrotic compounds derived from para-positioned 3,4,5-trisubstituted benzene","volume":"144","author":"Hong","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116344","article-title":"Design, synthesis, and biological evaluation of piperazine derivatives as pan-PPARs agonists for the treatment of liver fibrosis","volume":"269","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib35","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1021\/acs.jmedchem.0c01026","article-title":"Discovery and biological evaluation of N-Methyl-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as JAK1-selective inhibitors","volume":"64","author":"Park","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116311","article-title":"Synthesis and anti-liver fibrosis activity of imidazole and thiazole compounds containing amino acids","volume":"269","author":"Meng","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib37","doi-asserted-by":"crossref","first-page":"9537","DOI":"10.1021\/acs.jmedchem.1c00862","article-title":"Discovery of potent phosphodiesterase-9 inhibitors for the treatment of hepatic fibrosis","volume":"64","author":"Wu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib38","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.1021\/acs.jmedchem.4c00461","article-title":"Design, synthesis, and evaluation of dihydropyrimidine derivatives as selective PDE1 inhibitors for the treatment of liver fibrosis","volume":"67","author":"Zhao","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116029","article-title":"Design, synthesis and evaluation of novel UDCA-aminopyrimidine hybrids as ATX inhibitors for the treatment of hepatic and pulmonary fibrosis","volume":"264","author":"Hu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114685","article-title":"Discovery and evaluation of phenacrylanilide derivatives as novel potential anti-liver fibrosis agents","volume":"242","author":"Yue","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib41","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.bmcl.2017.01.089","article-title":"Novel 5-arylthio-5H-chromenopyridines as a new class of anti-fibrotic agents","volume":"27","author":"Patil","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117281_bib42","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1039\/D0RA09430G","article-title":"Synthesis and biological evaluation of fluorinated 3,4-dihydroquinolin-2(1H)-ones and 2-oxindoles for anti-hepatic fibrosis","volume":"11","author":"Li","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.117281_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116438","article-title":"Discovery of 1,8-naphthalidine derivatives as potent anti-hepatic fibrosis agents via repressing PI3K\/AKT\/Smad and JAK2\/STAT3 pathways","volume":"49","author":"Lu","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117096","article-title":"Design, synthesis and biological evaluation studies of novel anti-fibrosis agents bearing sulfoxide moiety","volume":"75","author":"Jiao","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129290","article-title":"Discovery and development of benzene sulfonamide derivatives as anti-hepatic fibrosis agents","volume":"88","author":"Niu","year":"2023","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117281_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202301429","article-title":"Therapeutic potential of benzimidazoisoquinoline derivatives in alleviating murine hepatic fibrosis","volume":"21","author":"Mekala","year":"2024","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2025.117281_bib47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejps.2013.11.017","article-title":"Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats","volume":"52","author":"Yang","year":"2014","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2025.117281_bib48","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10616-022-00548-w","article-title":"A novel matrine derivative, WM130, inhibits activation and movement of human hepatic stellate LX-2 cells by targeting cofilin 1","volume":"74","author":"Xu","year":"2022","journal-title":"Cytotechnology"},{"key":"10.1016\/j.ejmech.2025.117281_bib49","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13065-017-0327-8","article-title":"Synthesis and biological evaluation of tricyclic matrinic derivatives as a class of novel anti-HCV agents","volume":"11","author":"Tang","year":"2017","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.ejmech.2025.117281_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111972","article-title":"Quinolizidine alkaloids derivatives from Sophora alopecuroides Linn: bioactivities, structure-activity relationships and preliminary molecular mechanisms","volume":"188","author":"Li","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib51","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1021\/cr400307e","article-title":"(\u2212)-Cytisine and derivatives: synthesis, reactivity, and applications","volume":"114","author":"Rouden","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.117281_bib52","first-page":"777","article-title":"Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy","volume":"58","author":"Tutka","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2025.117281_bib53","doi-asserted-by":"crossref","DOI":"10.48130\/mpb-0024-0008","article-title":"Research progress on the biosynthesis, metabolic engineering, and pharmacology of bioactive compounds from the Lonicera genus","volume":"3","author":"Chen","year":"2024","journal-title":"Medicinal Plant Biology"},{"key":"10.1016\/j.ejmech.2025.117281_bib54","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/aps.2014.155","article-title":"The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K\/Akt\/Smad pathway","volume":"36","author":"Yu","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.117281_bib55","first-page":"169","article-title":"Establishment and application of a high-throughput drug screening model based on COL1A1 promoter for anti-liver fibrosis","volume":"50","author":"Zhao","year":"2015","journal-title":"Yaoxue Xuebao"},{"key":"10.1016\/j.ejmech.2025.117281_bib56","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1038\/s41598-018-24565-y","article-title":"Aloperine protects mice against bleomycin-induced pulmonary fibrosis by attenuating fibroblast proliferation and differentiation","volume":"8","author":"Yin","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117281_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejmech.2018.02.061","article-title":"Discovery and evolution of aloperine derivatives as novel anti-filovirus agents through targeting entry stage","volume":"149","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib58","first-page":"342","article-title":"Research progress in chemical constituents and pharmacological activities of gynostemma pentaphyllum","volume":"52","author":"Fan","year":"2017","journal-title":"Chin. Pharmaceut. J."},{"key":"10.1016\/j.ejmech.2025.117281_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2008.01.025","article-title":"Psidium guajava: a review of its traditional uses, phytochemistry and pharmacology","volume":"117","author":"Guti\u00e9rrez","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2025.117281_bib60","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/cjoc.201300308","article-title":"Iron(III) chloride catalyzed oxidative coupling reaction of 1,2\u2010diarylethylene derivatives","volume":"31","author":"Ji","year":"2013","journal-title":"Chin. J. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib61","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1021\/acs.orglett.9b02135","article-title":"Hantzsch ester-mediated benzannulation of diazo compounds under visible light irradiation","volume":"21","author":"Nagode","year":"2019","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.117281_bib62","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.2147\/DDDT.S180610","article-title":"Nudol, a phenanthrene derivative from <em>Dendrobium nobile<\/em>, induces cell cycle arrest and apoptosis and inhibits migration in osteosarcoma cells","volume":"13","author":"Zhang","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2025.117281_bib63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejmech.2018.02.063","article-title":"Design, synthesis, and biological evaluation of compounds with a new scaffold as anti-neuroinflammatory agents for the treatment of Alzheimer's disease","volume":"149","author":"Fang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib64","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1053\/jhep.2003.50176","article-title":"The normal liver harbors the vitamin D nuclear receptor in nonparenchymal and biliary epithelial cells","volume":"37","author":"Gascon-Barr\u00e9","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.117281_bib65","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3691","article-title":"The role of vitamin D in reducing cancer risk and progression","volume":"14","author":"Feldman","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.117281_bib66","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cell.2013.03.028","article-title":"A vitamin D receptor\/SMAD genomic circuit gates hepatic fibrotic response","volume":"153","author":"Ding","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.117281_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwq112","article-title":"Anticancer Vitamins du Jour\u2014The ABCED's So Far","volume":"172","author":"Byers","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ejmech.2025.117281_bib68","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejmech.2014.07.037","article-title":"Synthesis and preliminary biological evaluation of new antiproliferative aromatic analogues of 1\u03b1,25-dihydroxyvitamin D3","volume":"86","author":"Thomas","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib69","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/bcp.13781","article-title":"Update on pharmacologically-relevant vitamin D analogues","volume":"85","author":"Jones","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.117281_bib70","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jmedchem.0c01197","article-title":"Novel nonsecosteroidal vitamin D receptor modulator combined with gemcitabine enhances pancreatic cancer therapy through remodeling of the tumor microenvironment","volume":"64","author":"Kang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib71","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1021\/acs.jmedchem.8b00337","article-title":"Aromatic-based design of highly active and noncalcemic vitamin D receptor agonists","volume":"61","author":"Gogoi","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib72","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s42255-022-00642-5","article-title":"HK1 from hepatic stellate cell\u2013derived extracellular vesicles promotes progression of hepatocellular carcinoma","volume":"4","author":"Chen","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ejmech.2025.117281_bib73","doi-asserted-by":"crossref","first-page":"8444","DOI":"10.1073\/pnas.85.22.8444","article-title":"A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily","volume":"85","author":"Hazel","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117281_bib74","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2227777","article-title":"Design, synthesis, and evaluation of novel benzoylhydrazone derivatives as Nur77 modulators with potent antitumor activity against hepatocellular carcinoma","volume":"38","author":"He","year":"2023","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib75","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/ja0455547","article-title":"Alarm nmr: a rapid and robust experimental method to detect reactive false positives in biochemical screens","volume":"127","author":"Huth","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.117281_bib76","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.chembiol.2015.06.023","article-title":"Induction of autophagic death in cancer cells by agonizing TR3 and attenuating Akt2 activity","volume":"22","author":"Wang","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117281_bib77","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/nm.3777","article-title":"Orphan nuclear receptor NR4A1 regulates transforming growth factor-\u03b2 signaling and fibrosis","volume":"21","author":"Palumbo-Zerr","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.117281_bib78","doi-asserted-by":"crossref","first-page":"27412","DOI":"10.1073\/pnas.2002997117","article-title":"Blocking PPAR\u03b3 interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression","volume":"117","author":"Yang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2025.117281_bib79","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.matbio.2017.12.003","article-title":"Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts","volume":"67","author":"Avery","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ejmech.2025.117281_bib80","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-0035-1548759","article-title":"Responses from authors","volume":"36","author":"Li","year":"2015","journal-title":"Int. J. Sports Med."},{"key":"10.1016\/j.ejmech.2025.117281_bib81","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nchembio.1069","article-title":"The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK","volume":"8","author":"Zhan","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117281_bib82","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/35013000","article-title":"Roles of PPARs in health and disease","volume":"405","author":"Kersten","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117281_bib83","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejmech.2025.117281_bib84","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1021\/jm101360s","article-title":"Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators","volume":"55","author":"Pirat","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.toxlet.2011.01.013","article-title":"Lack of PPAR\u03b1 exacerbates lipopolysaccharide-induced liver toxicity through STAT1 inflammatory signaling and increased oxidative\/nitrosative stress","volume":"202","author":"Yoo","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejmech.2025.117281_bib86","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1021\/acs.jmedchem.1c02002","article-title":"Design, synthesis, and biological evaluation of triazolone derivatives as potent ppar\u03b1\/\u03b4 dual agonists for the treatment of nonalcoholic steatohepatitis","volume":"65","author":"Feng","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib87","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1021\/acs.jmedchem.2c02123","article-title":"Discovery of the first subnanomolar ppar\u03b1\/\u03b4 dual agonist for the treatment of cholestatic liver diseases","volume":"66","author":"Feng","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107940","article-title":"Design, synthesis and FXR partial agonistic activity of anthranilic acid derivatives bearing aryloxy moiety as therapeutic agents for metabolic dysfunction-associated steatohepatitis","volume":"153","author":"Chen","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib89","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1021\/acs.jmedchem.2c01918","article-title":"Discovery of the first-in-class intestinal restricted FXR and FABP1 dual modulator ZLY28 for the treatment of nonalcoholic fatty liver disease","volume":"66","author":"Ren","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib90","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41467-019-14138-6","article-title":"SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117281_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117082","article-title":"Design, synthesis, and biological evaluation of novel highly potent FXR agonists bearing piperidine scaffold","volume":"282","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115614","article-title":"Design, synthesis, and biological studies of novel sulfonamide derivatives as farnesoid X receptor agonists","volume":"258","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib93","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117281_bib94","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1401867","article-title":"Mechanisms of jak\/STAT signaling in immunity and disease","volume":"194","author":"Villarino","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2025.117281_bib95","first-page":"129","article-title":"Transforming growth factor \u03b21 promotes migration and invasion in HepG2 cells: epithelial-to-mesenchymal transition via JAK\/STAT3 signaling","volume":"41","author":"Lin","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117281_bib96","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3892\/ijmm.2016.2692","article-title":"Targeted blockade of JAK\/STAT3 signaling inhibits proliferation, migration and collagen production as well as inducing the apoptosis of hepatic stellate cells","volume":"38","author":"Gu","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejmech.2025.117281_bib97","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s40264-017-0622-2","article-title":"Analysis of spontaneous postmarket case reports submitted to the FDA regarding thromboembolic adverse events and JAK inhibitors","volume":"41","author":"Verden","year":"2018","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejmech.2025.117281_bib98","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1021\/acsmedchemlett.7b00154","article-title":"JAK2 JH2 fluorescence polarization assay and crystal structures for complexes with three small molecules","volume":"8","author":"Newton","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117281_bib99","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-\u03b2 family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117281_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106723","article-title":"Synthesis of and anti-fibrotic effect of pyrazole derivative J-1048: inhibition of ALK5 as a novel approach to liver fibrosis targeting inflammation","volume":"139","author":"Yang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105715","article-title":"The in vitro and in vivo study of a pyrazole derivative, J-1063, as a novel anti-liver fibrosis agent: synthesis, biological evaluation, and mechanistic analysis","volume":"122","author":"Zheng","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib102","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117281_bib103","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.1021\/acs.jmedchem.0c00711","article-title":"Discovery of novel selective and orally bioavailable phosphodiesterase-1 inhibitors for the efficient treatment of idiopathic pulmonary fibrosis","volume":"63","author":"Wu","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2018.00180","article-title":"Autotaxin in pathophysiology and pulmonary fibrosis","volume":"5","author":"Ninou","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.ejmech.2025.117281_bib105","doi-asserted-by":"crossref","first-page":"39436","DOI":"10.1074\/jbc.M205623200","article-title":"Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase","volume":"277","author":"Tokumura","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib106","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1021\/acs.jmedchem.6b01743","article-title":"Rational design of autotaxin inhibitors by structural evolution of endogenous modulators","volume":"60","author":"Keune","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib107","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1083\/jcb.200204026","article-title":"Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production","volume":"158","author":"Umezu-Goto","year":"2002","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.ejmech.2025.117281_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.01.005","article-title":"Versatile pharmacological actions of YC-1: anti-platelet to anticancer","volume":"207","author":"Chun","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2025.117281_bib109","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1039\/C5OB00710K","article-title":"The design, synthesis, and biological evaluation of novel YC-1 derivatives as potent anti-hepatic fibrosis agents","volume":"13","author":"Xiao","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2025.117281_bib110","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1016\/j.bmcl.2012.04.074","article-title":"New substituted 4H-chromenes as anticancer agents","volume":"22","author":"Patil","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117281_bib111","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.apsb.2016.11.005","article-title":"A novel class of apical sodium--dependent bile salt transporter inhibitors: 1-(2,4-bifluorophenyl)-7-dialkylamino-1,8-naphthyridine-3-carboxamides","volume":"7","author":"Liu","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.117281_bib112","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cclet.2016.07.024","article-title":"Synthesis and in vitro antitumor activity of novel naphthyridinone derivatives","volume":"28","author":"Jia","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117281_bib113","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1680\/jadcr.17.00001","article-title":"A newly developed strength-graded material and its deformation behaviour","volume":"30","author":"Zhao","year":"2018","journal-title":"Adv. Cement Res."},{"key":"10.1016\/j.ejmech.2025.117281_bib114","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1006\/bbrc.1996.1508","article-title":"Inhibitory effect of tranilast on activation and transforming growth factor \u03b21 expression in cultured rat stellate cells","volume":"227","author":"Ikeda","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2025.117281_bib115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.phrs.2014.10.009","article-title":"Tranilast: a review of its therapeutic applications","volume":"91","author":"Darakhshan","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.117281_bib116","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.22338","article-title":"Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis","volume":"48","author":"Uno","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.117281_bib117","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1021\/acsmedchemlett.0c00433","article-title":"Oxetanyl sulfoxide MMS-350 ameliorates pulmonary fibrosis in vitro, in vivo, and ex vivo","volume":"11","author":"Mlakar","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117281_bib118","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.3390\/molecules27123738","article-title":"Established liposome-coated IMB16-4 polymeric nanoparticles (LNPs) for increasing cellular uptake and anti-fibrotic effects in vitro","volume":"27","author":"Niu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117281_bib119","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3390\/molecules26061545","article-title":"Novel IMB16-4 compound loaded into silica nanoparticles exhibits enhanced oral bioavailability and increased anti-liver fibrosis in vitro","volume":"26","author":"Niu","year":"2021","journal-title":"Molecules"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425000467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T11:53:20Z","timestamp":1740398000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425000467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":119,"alternative-id":["S0223523425000467"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117281","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in small molecule design strategies against hepatic fibrosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117281"}}